A carregar...
Precision Therapy of Pancreatic Cancer: From Bench to Bedside
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC), with a mortality rate of 94% and a 5-year-survival rate of only 8%, is one of the deadliest cancer entities worldwide, and early diagnostic methods as well as effective therapies are urgently needed. SUMMARY: This review summarizes current clinica...
Na minha lista:
| Publicado no: | Visc Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger GmbH
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7590788/ https://ncbi.nlm.nih.gov/pubmed/33178734 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000509232 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|